Innovating Works

FONDATION CARDIOMETABOLISME NUTRITION

Desconocido
LIVERAIM: A Biomarker Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Thera... FONDATION CARDIOMETABOLISME NUTRITION participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-03-single-stage Liver cirrhosis and liver cancer are common and responsible for high morbidity, impaired quality of life, major costs for healthcare systems...
2023-11-27 - 2030-02-28 | Financiado
DCM-NEXT: Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy pati... FONDATION CARDIOMETABOLISME NUTRITION participó en un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDERCHALLENGES-01 Dilated Cardiomyopathy (DCM) is a heart muscle disorder characterised by thinning and stretching of the heart ventricles, making it harder f...
2023-06-20 - 2027-09-30 | Financiado
HORUS: Casting light on HOst-cytomegaloviRUs interaction in Solid organ transplantation FONDATION CARDIOMETABOLISME NUTRITION participó en un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 "Solid organ transplantation (SOT) is the treatment of choice for end-stage organ failure but the immunosuppressive drugs used to prevent gr...
2022-05-30 - 2027-10-31 | Financiado
MAESTRIA: Machine Learning Artificial Intelligence Early Detection Stroke Atrial Fibrillation FONDATION CARDIOMETABOLISME NUTRITION participó en un H2020: H2020-SC1-BHC-2018-2020 Atrial fibrillation (AF) and stroke are major health care problems in Europe. They are most often the clinical expression of atrial cardiomy...
2021-01-21 - 2026-02-28 | Financiado
EU-PEARL: EU Patient cEntric clinicAl tRial pLatform FONDATION CARDIOMETABOLISME NUTRITION participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage EU-PEARL has the ambition of transforming the current approach of conducting single-compound clinical trials into the use of cross-company I...
2019-11-27 - 2023-04-30 | Financiado
LITMUS: Liver Investigation Testing Marker Utility in Steatohepatitis FONDATION CARDIOMETABOLISME NUTRITION participó en un H2020: H2020-JTI-IMI2-2016-09-two-stage Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, Non-Alcoholic Fatty Liv...
2017-10-09 - 2024-02-29 | Financiado
EPoS: Elucidating Pathways of Steatohepatitis FONDATION CARDIOMETABOLISME NUTRITION participó en un H2020: H2020-PHC-2014-2015 Strongly associated with the epidemics of obesity and type 2 diabetes mellitus (T2DM) that are testing healthcare systems worldwide, Non-Alc...
2015-04-07 - 2019-10-31 | Financiado
COMBACTE-MAGNET: Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections FONDATION CARDIOMETABOLISME NUTRITION participó en un FP6: Antimicrobial resistance (AMR) is a major global public health threat, and most troublesome is the rapid emergence and dissemination of mult...
2015-01-01 - 2021-12-31 | Financiado
COMBACTE-MAGNET: Combatting Bacterial Resistance in Europe Molecules against Gram Negative Infections FONDATION CARDIOMETABOLISME NUTRITION participó en un FP7: Antimicrobial resistance (AMR) is a major global public health threat, and most troublesome is the rapid emergence and dissemination of mult...
Financiado
METACARDIS: Metagenomics in Cardiometabolic Diseases FONDATION CARDIOMETABOLISME NUTRITION participó en un FP7: METACARDIS applies a systems medicine multilevel approach to identify biological relationships between gut microbiota, assessed by metagenom...
Financiado
MON4STRAT: Therapeutic Beta Lactam Monitoring for Stratified Treatment of hospital acquired pneumonia improved... FONDATION CARDIOMETABOLISME NUTRITION participó en un FP7: Stratified clinical treatment interventions meeting patient-specific efficacy (pharmacodynamics) while at the same time lowering the risk of...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.